相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 IL-31Ra 抗体 (奈莫利珠单抗),生物类似药,科研用途 [ CAS: 1476039-58-3]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
IL-31Ra
- 抗体名:
IL-31Ra
- 规格:
1mg
BioSIM 抗人 IL-31Ra 抗体 (奈莫利珠单抗生物类似物)
产品基本信息
英文名称:BioSIM anti-Human IL-31Ra Antibody (Nemolizumab Biosimilar), Research Grade中文名称:BioSIM 抗人 IL-31Ra 抗体 (奈莫利珠单抗),生物类似药,科研用途 [ CAS: 1476039-58-3 ]
产品类型:二抗
供应商:InvivoCrown
产品货号:SIM0510-1mg
产品规格:1mg
产品简介
BioSIM 抗人 IL-31Ra 抗体是一种高特异性科研级试剂,作为奈莫利珠单抗(Nemolizumab)的生物类似物,具有与治疗性抗体相同的可变区结构。该抗体靶向人IL-31受体α(IL-31Ra),是研究IL-31信号通路及其在瘙痒和炎症反应中作用的理想工具。
产品背景与应用价值
IL-31是由活化的T细胞产生的细胞因子,通过与IL-31Ra结合,参与多种生理和病理过程,尤其是介导瘙痒和炎症反应。奈莫利珠单抗通过阻断IL-31与IL-31Ra的结合,能够有效中断特应性皮炎(AD)和慢性瘙痒症(PN)中的瘙痒-抓挠循环,为相关疾病的治疗提供了新的思路。
研究领域
- 瘙痒机制研究
- 特应性皮炎(AD)病理生理学
- 神经免疫相互作用
- 止痒疗法开发
- IL-31信号传导通路研究
技术参数
- 免疫原性:详情请参考产品说明书
- 来源宿主:人源化(Humanized)
- 反应性:仅针对人源样本(Human)
- 纯度:根据供应商提供的技术规格
- 浓度:根据产品规格确定
应用方法
- ELISA (酶联免疫吸附测定)
- FACS (流式细胞术)
- Functional assay (功能实验)
- Research in vivo (体内研究)
储存条件
重要提示:为保持抗体活性,请避免反复冻融。
- 短期储存(1-2周):4°C
- 中期储存(最长12个月):-20°C
- 长期储存:-80°C
订购信息
产品货号:SIM0510-1mg
包装规格:1mg
供应商:InvivoCrown
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM anti-Human IL-31Ra Antibody (Nemolizumab Biosimilar)
Product Basic Information
English Name: BioSIM anti-Human IL-31Ra Antibody (Nemolizumab Biosimilar), Research GradeChinese Name: BioSIM 抗人 IL-31Ra 抗体 (奈莫利珠单抗),生物类似药,科研用途 [ CAS: 1476039-58-3 ]
Product Type: Secondary Antibody
Supplier: InvivoCrown
Catalog Number: SIM0510-1mg
Specification: 1mg
Product Introduction
BioSIM anti-Human IL-31Ra Antibody is a highly specific research-grade reagent that serves as a biosimilar of Nemolizumab, featuring identical variable region structure to the therapeutic antibody. This antibody targets human IL-31 receptor alpha (IL-31Ra) and is an ideal tool for studying the IL-31 signaling pathway and its role in pruritus and inflammatory responses.
Product Background and Application Value
IL-31 is a cytokine produced by activated T cells that, upon binding to IL-31Ra, participates in various physiological and pathological processes, particularly mediating pruritus and inflammatory responses. Nemolizumab effectively interrupts the itch-scratch cycle in atopic dermatitis (AD) and prurigo nodularis (PN) by blocking the binding of IL-31 to IL-31Ra, providing new approaches for treating related diseases.
Research Areas
- Pruritus mechanism research
- Atopic dermatitis (AD) pathophysiology
- Neuroimmune interactions
- Anti-pruritic therapy development
- IL-31 signaling pathway research
Technical Parameters
- Immunogenicity: Please refer to the product manual for details
- Source Host: Humanized
- Reactivity: Human only
- Purity: According to the technical specifications provided by the supplier
- Concentration: Determined according to product specifications
Application Methods
- ELISA (Enzyme-Linked Immunosorbent Assay)
- FACS (Flow Cytometry)
- Functional assay
- Research in vivo
Storage Conditions
Important Note: To maintain antibody activity, please avoid repeated freeze-thaw cycles.
- Short-term storage (1-2 weeks): 4°C
- Medium-term storage (up to 12 months): -20°C
- Long-term storage: -80°C
Ordering Information
Catalog Number: SIM0510-1mg
Packaging Size: 1mg
Supplier: InvivoCrown
Note: The above information may change due to product optimization and upgrading, etc. Please consult Yaokeen Company for specific information.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






